Abstract
Development of serotype-specific monoclonal antibodies against botulinum neurotoxins A, B and E, based on a trivalent immunization protocol and simultaneous differential robotic screen
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have